Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment (NCT05039554) | Clinical Trial Compass
RecruitingNot Applicable
Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment
United States123 participantsStarted 2023-02-02
Plain-language summary
The proposed IMPOWR Research Center at Montefiore-Einstein (IMPOWR-ME) will create a multidisciplinary and synergistic program of research to test multimodal treatments that address both chronic pain and opioid use disorder. IMPOWR-ME will generate critical knowledge about the effectiveness, implementation, and cost effectiveness of providing Acceptance and Commitment Therapy and/or a care management smartphone app for individuals in primary care-based buprenorphine treatment. Patients with lived experience with chronic pain and/or opioid use disorder, patient and policy advocates, payors, and health system partners will be engaged in all stages of the research. IMPOWR-ME is well-positioned to become a long-lasting hub for stakeholder-engaged research with multidisciplinary senior and early stage investigators focused on reducing overdose through better treatments for OUD and CP.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 18 years old or older;
✓. English or Spanish proficiency;
✓. receiving BUP treatment for OUD for at least 14 days (thus a stabilized BUP dose); and
✓. CP with at least moderate pain severity (score greater than or equal to 4 on Pain, Enjoyment of Life and General Activity (PEG) scale). Comorbid psychiatric conditions and use of psychotropic medications will be allowed
Exclusion criteria
✕. Acute exacerbation of psychiatric conditions precluding the ability to participate in the study (e.g., acute mania, active suicidality/homicidality, psychosis);
✕. psychotropic medication changes within the past three months prior to enrollment;
✕. CP related to malignancy;
✕. received ACT or similar therapeutic intervention in the past;
✕. initiated psychotherapy within the past three months;